Document qmRGzgmnOn184VL7EEGMYLgb5

To: 'Howard Feldman' <Feldman@api.org>; BenzConsort-OC@listserve.api.org <BenzConsort-OC@listserve.api.org>; Myron Harrison (E-mail) <myron.c.harrison@exxonmobil.com> From: Clegg, Patsy M SCC-DCS/22 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Brenda Hargett <Hargettb@api.org>; Harry Ng <Ng@api.org>; Bob Greco <Greco@api.org>; Cagen, Stuart Z SHLOIL-SHOIL-SHS <stuart.cagen@shell.com>; Tsai, Shan P SHLOIL- SHS <Shan.Tsai@shell.com>; Snyder, Phil J SCC-DCS/2 <phil.snyder@shell.com>; Williams, Elizabeth J SCAI-DCS/22 <elizabeth.williams@shell.com>; Sykes, Paul B SCC-DCS/23 <PauI.Sykes@shell.com> Bcc: Received Date: 2007-04-0221 :28:29 GMT Subject: RE: request from Cinpathogen Shell has reviewed Dr. Irons' proposal for $2M in advance funding for the SHS laboratory. We are proposing a schedule of payments as outlined below. Shell proposes the following response to the request for an advance of $2M from Dr. Irons: Staff costs June 510K Staff were paid for Jan - March; we only need to provide funding for April - Lab liabilities 150K Lab expenses 500K Contingency 200K Total 1.36M Proposed Payment Schedule: ASAP Payment 680K May 15 680K Balance of 6,559,860 is paid in installments. 6,559,860 Total approved increase - 800,000 lab personnel and publications = 5,759,860 Study completion budget - 1,360,000 Advance 4,399,86013 = 1,466,620/payment based on progress as reported by QA/QC process July 1 07 1,466,620 Sept 1 07 1,466,620 Nov 1 07 1,466,620 The $400K for personnel and $400K for publications be paid as follows: Jan 1 08 July 1 08 800,000 1/2 of personnel and 1/2 of publications 800,000 1/2 of personnel and 1/2 of publications; if evidence of manuscripts is provided Regards, Patsy Patsy Clegg SH ELL-MCCLU RG-OS4930 Product Steward, HSSE Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Business Success through HSSE Excellence -----Original Message----From: Howard Feldman [mailto:Feldman@api.org] Sent: Sunday, April 01, 2007 9:54 PM To: BenzConsort-OC@listserve.api.org Cc: Brenda Hargett; Harry Ng; Bob Greco Subject: request from Cinpathogen BHRC OC, Attached is the request for $2 million in expedited funding from Cinpathogen. I would like to discuss this ASAP with the Oversight Committee as scheduling permits. I will call you individually on Monday and determine whether we need a conference call. Howard From: Richard.lrons@UCHSC.edu [mailto:Richard.lrons@UCHSC.edu] Sent: Saturday, March 31, 2007 1:04 AM To: Howard Feldman Subject: RE: left you two phone msgs Howard, Attached please find my request for expedited funding. I have been tied up in conference calls and meetings today and only received your messages this evening. I will be similarly engaged for most of Monday as well. As you will see from my letter I am in direct contact with the Fudan administration, and if I have anything new of substance to communicate to the BHRC I will inform you on Monday. Sincerely, Richard From: Howard Feldman [mailto:Feldman@api.org] Sent: Fri 3/30/2007 3:36 PM To: Irons, Richard Subject: left you two phone msgs SH ELL-MCCLU RG-OS4931 Howard J. Feldman Director Regulatory & Scientific Affairs 1220 L Street, NW Washington, DC 20005-4070 USA Telephone 202-682-8340 Fax 202-682-8270 E-mail feldman@api.org SH ELL-MCCLU RG-OS4932